Skip to main content
Erschienen in: Supportive Care in Cancer 3/2012

01.03.2012 | Original Article

Comparison of pain response and functional interference outcomes between spinal and non-spinal bone metastases treated with palliative radiotherapy

verfasst von: Liang Zeng, Edward Chow, Liying Zhang, Shaelyn Culleton, Lori Holden, Florencia Jon, Luluel Khan, May Tsao, Elizabeth Barnes, Cyril Danjoux, Arjun Sahgal

Erschienen in: Supportive Care in Cancer | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study was to compare functional interference and pain response outcomes using the Brief Pain Inventory (BPI) for patients treated with palliative radiotherapy to spine versus non-spine bones and determine if dose fractionation was associated with each group’s respective response.

Materials and methods

Patients treated for painful bone metastases with palliative radiotherapy during May 2003 to June 2007 were analyzed. The BPI was utilized at baseline and monthly for 6 months post-radiation. Pain response was determined using International Bone Metastases Consensus response definitions. Wilcoxon rank–sum test (for continuous variable), Fisher exact test (for categorical value), and two-way analysis of variance were used for comparisons, and a p value of ≤0.05 was considered statistically significant.

Results

Three hundred eighty-six patients were analyzed, 62% were treated with a single fraction, 38% with multiple fractions. Pain and functional interference scores significantly improved over time in both spine and non-spine sites. At 3 months, 42% of all patients had a partial response, and 25% had a complete response. Location of bone metastases and radiotherapy dose were not predictive factors for pain response nor functional interference following radiation treatment.

Conclusion

Spine and non-spine bone metastases exhibited similar pain and functional interference improvements over a period of 6 months post-radiotherapy. There were, however, high attrition rates as expected with palliative studies, with approximately half the patients remaining in this study by 3 months and a fifth by 6 months. A single 8 Gy resulted in equal benefits in terms of both pain response and improvement in function.
Literatur
2.
Zurück zum Zitat Hird A, Chow E, Zhang L et al (2009) Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three Canadian cancer centers. Int J Radiat Oncol Biol Phys 75(1):193–197PubMedCrossRef Hird A, Chow E, Zhang L et al (2009) Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three Canadian cancer centers. Int J Radiat Oncol Biol Phys 75(1):193–197PubMedCrossRef
3.
Zurück zum Zitat Wu JSY, Monk G, Clark T et al (2006) Palliative radiotherapy improves pain and reduces functional interference in patients with painful bone metastases: a quality assurance study. Clin Oncol 18(7):539–544CrossRef Wu JSY, Monk G, Clark T et al (2006) Palliative radiotherapy improves pain and reduces functional interference in patients with painful bone metastases: a quality assurance study. Clin Oncol 18(7):539–544CrossRef
4.
Zurück zum Zitat Schocker JD, Brady LW (1982) Radiation therapy for bone metastasis. Clin Orthop Relat Res 169:38–43PubMed Schocker JD, Brady LW (1982) Radiation therapy for bone metastasis. Clin Orthop Relat Res 169:38–43PubMed
5.
Zurück zum Zitat Heyszl G (1980) Radiation therapy of bone metastases. Wien Med Wochenschr 130(22):714–717PubMed Heyszl G (1980) Radiation therapy of bone metastases. Wien Med Wochenschr 130(22):714–717PubMed
6.
Zurück zum Zitat Niang U, Kamer S, Ozsaran Z et al (2009) The management of painful bone metastases with biphosphonates and palliative radiotherapy: a retrospective evaluation of 372 cases. J BUON 14(2):245–249PubMed Niang U, Kamer S, Ozsaran Z et al (2009) The management of painful bone metastases with biphosphonates and palliative radiotherapy: a retrospective evaluation of 372 cases. J BUON 14(2):245–249PubMed
7.
Zurück zum Zitat Konski A, James J, Hartsell W et al (2009) Economic analysis of radiation therapy oncology group 97–14: multiple versus single fraction radiation treatment of patients with bone metastases. Am J Clin Oncol Cancer Clin Trials 32(4):423–428 Konski A, James J, Hartsell W et al (2009) Economic analysis of radiation therapy oncology group 97–14: multiple versus single fraction radiation treatment of patients with bone metastases. Am J Clin Oncol Cancer Clin Trials 32(4):423–428
8.
Zurück zum Zitat Horvat AG, Kovac V, Strojan P (2009) Radiotherapy in palliative treatment of painful bone metastases. Radiol Oncol 43(4):213–224CrossRef Horvat AG, Kovac V, Strojan P (2009) Radiotherapy in palliative treatment of painful bone metastases. Radiol Oncol 43(4):213–224CrossRef
9.
Zurück zum Zitat Cleeland CS, Ryan KM (1994) Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore 23(2):129–138PubMed Cleeland CS, Ryan KM (1994) Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore 23(2):129–138PubMed
10.
Zurück zum Zitat Wu JS, Beaton D, Smith PM et al (2010) Patterns of pain and interference in patients with painful bone metastases: a brief pain inventory validation study. J Pain Symptom Manage 39(2):230–240PubMedCrossRef Wu JS, Beaton D, Smith PM et al (2010) Patterns of pain and interference in patients with painful bone metastases: a brief pain inventory validation study. J Pain Symptom Manage 39(2):230–240PubMedCrossRef
11.
Zurück zum Zitat Dworkin RH, Turk DC, Farrar JT et al (2005) Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 113(1–2):9–19PubMedCrossRef Dworkin RH, Turk DC, Farrar JT et al (2005) Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 113(1–2):9–19PubMedCrossRef
12.
Zurück zum Zitat Chow E, Wu JS, Hoskin P et al (2002) International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 64(3):275–280PubMedCrossRef Chow E, Wu JS, Hoskin P et al (2002) International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 64(3):275–280PubMedCrossRef
13.
Zurück zum Zitat Klepstad P, Loge JH, Borchgrevink PC et al (2002) The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients. J Pain Symptom Manage 24(5):517–525PubMedCrossRef Klepstad P, Loge JH, Borchgrevink PC et al (2002) The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients. J Pain Symptom Manage 24(5):517–525PubMedCrossRef
14.
Zurück zum Zitat Badia X, Muriel C, Gracia A et al (2003) Validation of the Spanish version of the brief pain inventory in patients with oncological pain. Med Clin Barc 120(2):52–59PubMedCrossRef Badia X, Muriel C, Gracia A et al (2003) Validation of the Spanish version of the brief pain inventory in patients with oncological pain. Med Clin Barc 120(2):52–59PubMedCrossRef
15.
Zurück zum Zitat Yun YH, Mendoza TR, Heo DS et al (2004) Development of a cancer pain assessment tool in Korea: a validation study of a Korean version of the brief pain inventory. Oncology 66(6):439–444PubMedCrossRef Yun YH, Mendoza TR, Heo DS et al (2004) Development of a cancer pain assessment tool in Korea: a validation study of a Korean version of the brief pain inventory. Oncology 66(6):439–444PubMedCrossRef
16.
Zurück zum Zitat Aisyaturridha A, Naing L, Nizar AJ (2006) Validation of the Malay brief pain inventory questionnaire to measure cancer pain. J Pain Symptom Manage 31(1):13–21PubMedCrossRef Aisyaturridha A, Naing L, Nizar AJ (2006) Validation of the Malay brief pain inventory questionnaire to measure cancer pain. J Pain Symptom Manage 31(1):13–21PubMedCrossRef
17.
Zurück zum Zitat Kalyadina SA, Ionova TI, Ivanova MO et al (2008) Russian brief pain inventory: validation and application in cancer pain. J Pain Symptom Manage 35(1):95–102PubMedCrossRef Kalyadina SA, Ionova TI, Ivanova MO et al (2008) Russian brief pain inventory: validation and application in cancer pain. J Pain Symptom Manage 35(1):95–102PubMedCrossRef
18.
Zurück zum Zitat Chaudakshetrin P (2009) Validation of the Thai version of brief pain inventory (BPI-T) in cancer patients. J Med Assoc Thai 92(1):34–40PubMed Chaudakshetrin P (2009) Validation of the Thai version of brief pain inventory (BPI-T) in cancer patients. J Med Assoc Thai 92(1):34–40PubMed
19.
Zurück zum Zitat Dicle A, Karayurt O, Dirimese E (2009) Validation of the Turkish version of the brief pain inventory in surgery patients. Pain Manag Nurs 10(2):107–113.e2PubMedCrossRef Dicle A, Karayurt O, Dirimese E (2009) Validation of the Turkish version of the brief pain inventory in surgery patients. Pain Manag Nurs 10(2):107–113.e2PubMedCrossRef
20.
Zurück zum Zitat Harris K, Li K, Flynn C et al (2007) Worst, average or current pain in the brief pain inventory: which should be used to calculate the response to palliative radiotherapy in patients with bone metastases? Clin Oncol (R Coll Radiol) 19(7):523–527CrossRef Harris K, Li K, Flynn C et al (2007) Worst, average or current pain in the brief pain inventory: which should be used to calculate the response to palliative radiotherapy in patients with bone metastases? Clin Oncol (R Coll Radiol) 19(7):523–527CrossRef
21.
Zurück zum Zitat Hartsell WF, Scott CB, Bruner DW et al (2005) Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 97(11):798–804PubMedCrossRef Hartsell WF, Scott CB, Bruner DW et al (2005) Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 97(11):798–804PubMedCrossRef
22.
Zurück zum Zitat Saxena A, Mendoza T, Cleeland CS (1999) The assessment of cancer pain in north India: the validation of the Hindi brief pain inventory - BPI-H. J Pain Symptom Manage 17(1):27–41PubMedCrossRef Saxena A, Mendoza T, Cleeland CS (1999) The assessment of cancer pain in north India: the validation of the Hindi brief pain inventory - BPI-H. J Pain Symptom Manage 17(1):27–41PubMedCrossRef
23.
Zurück zum Zitat Jeon S, Given CW, Sikorskii A et al (2009) Do interference-based cut-points differentiate mild, moderate, and severe levels of 16 cancer-related symptoms over time? J Pain Symptom Manage 37(2):220–232PubMedCrossRef Jeon S, Given CW, Sikorskii A et al (2009) Do interference-based cut-points differentiate mild, moderate, and severe levels of 16 cancer-related symptoms over time? J Pain Symptom Manage 37(2):220–232PubMedCrossRef
Metadaten
Titel
Comparison of pain response and functional interference outcomes between spinal and non-spinal bone metastases treated with palliative radiotherapy
verfasst von
Liang Zeng
Edward Chow
Liying Zhang
Shaelyn Culleton
Lori Holden
Florencia Jon
Luluel Khan
May Tsao
Elizabeth Barnes
Cyril Danjoux
Arjun Sahgal
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 3/2012
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1144-6

Weitere Artikel der Ausgabe 3/2012

Supportive Care in Cancer 3/2012 Zur Ausgabe

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.